Annual Cash & Cash Equivalents
$5.93 M
+$3.81 M+179.83%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual cash & cash equivalents is $5.93 million, with the most recent change of +$3.81 million (+179.83%) on December 31, 2023.
- During the last 3 years, BGLC annual cash & cash equivalents has risen by +$3.14 million (+112.70%).
- BGLC annual cash & cash equivalents is now at all-time high.
Performance
BGLC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.14 M
-$1.28 M-23.58%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly cash and cash equivalents is $4.14 million, with the most recent change of -$1.28 million (-23.58%) on September 30, 2024.
- Over the past year, BGLC quarterly cash and cash equivalents has dropped by -$1.28 million (-23.58%).
- BGLC quarterly cash and cash equivalents is now -32.69% below its all-time high of $6.15 million, reached on September 30, 2023.
Performance
BGLC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BGLC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +179.8% | -23.6% |
| 3 y3 years | +112.7% | +109.7% |
| 5 y5 years | +370.5% | +109.7% |
BGLC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +179.8% | -32.7% | +208.7% |
| 5 y | 5-year | at high | +590.2% | -32.7% | +502.0% |
| alltime | all time | at high | +590.2% | -32.7% | +502.0% |
BioNexus Gene Lab Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.14 M(-23.6%) |
| Jun 2024 | - | $5.41 M(-7.2%) |
| Mar 2024 | - | $5.83 M(-1.6%) |
| Dec 2023 | $5.93 M(+179.8%) | $5.93 M(-3.5%) |
| Sep 2023 | - | $6.15 M(+249.5%) |
| Jun 2023 | - | $1.76 M(-10.9%) |
| Mar 2023 | - | $1.97 M(-6.9%) |
| Dec 2022 | $2.12 M(-0.2%) | $2.12 M(+44.9%) |
| Sep 2022 | - | $1.46 M(+9.1%) |
| Jun 2022 | - | $1.34 M(-27.3%) |
| Mar 2022 | - | $1.84 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.12 M(-23.8%) | - |
| Dec 2021 | - | $2.12 M(+24.9%) |
| Sep 2021 | - | $1.70 M(+14.7%) |
| Jun 2021 | - | $1.48 M(-40.1%) |
| Mar 2021 | - | $2.47 M(-11.2%) |
| Dec 2020 | $2.79 M(+224.5%) | $2.79 M(+305.7%) |
| Sep 2020 | - | $687.20 K(-5.7%) |
| Jun 2020 | - | $728.50 K(-7.1%) |
| Mar 2020 | - | $783.90 K(-8.8%) |
| Dec 2019 | $859.10 K(-31.8%) | $859.10 K |
| Dec 2018 | $1.26 M | - |
FAQ
- What is BioNexus Gene Lab annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual cash & cash equivalents year-on-year change?
- What is BioNexus Gene Lab quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly cash and cash equivalents year-on-year change?
What is BioNexus Gene Lab annual cash & cash equivalents?
The current annual cash & cash equivalents of BGLC is $5.93 M
What is the all time high annual cash & cash equivalents for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual cash & cash equivalents is $5.93 M
What is BioNexus Gene Lab annual cash & cash equivalents year-on-year change?
Over the past year, BGLC annual cash & cash equivalents has changed by +$3.81 M (+179.83%)
What is BioNexus Gene Lab quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BGLC is $4.14 M
What is the all time high quarterly cash and cash equivalents for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly cash and cash equivalents is $6.15 M
What is BioNexus Gene Lab quarterly cash and cash equivalents year-on-year change?
Over the past year, BGLC quarterly cash and cash equivalents has changed by -$1.28 M (-23.58%)